Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,230 | -22,830 | -8,547 | -3,597 | -25,469 |
| Depreciation Amortization | 2,311 | 1,623 | 869 | 339 | 632 |
| Income taxes - deferred | 164 | N/A | N/A | N/A | N/A |
| Accounts receivable | 5,343 | N/A | N/A | N/A | -4,055 |
| Accounts payable and accrued liabilities | -4,354 | N/A | N/A | N/A | 1,257 |
| Other Working Capital | -16,377 | -14,792 | -20,250 | -13,455 | -32,121 |
| Other Operating Activity | 4,247 | 3,520 | 3,019 | 1,582 | 7,289 |
| Operating Cash Flow | $-45,896 | $-32,479 | $-24,909 | $-15,131 | $-52,467 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,726 | -2,148 | -2,988 | -1,927 | -2,462 |
| Purchase Of Investment | -41,499 | -41,178 | -38,525 | -26,032 | -59,317 |
| Sale Of Investment | 83,437 | 67,687 | 47,523 | 28,373 | 71,617 |
| Investing Cash Flow | $39,212 | $24,361 | $6,010 | $414 | $9,838 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,115 | 10,040 | 416 | N/A | 32,166 |
| Financing Cash Flow | $10,115 | $10,040 | $416 | $N/A | $32,166 |
| Exchange Rate Effect | 4,745 | 2,708 | 525 | -112 | -2,144 |
| Beginning Cash Position | 62,260 | 62,260 | 62,260 | 62,260 | 74,867 |
| End Cash Position | 70,436 | 66,890 | 44,302 | 47,431 | 62,260 |
| Net Cash Flow | $8,176 | $4,630 | $-17,958 | $-14,829 | $-12,607 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,896 | -32,479 | -24,909 | -15,131 | -52,467 |
| Capital Expenditure | -2,726 | -2,148 | -2,988 | -1,927 | -2,462 |
| Free Cash Flow | -48,622 | -34,627 | -27,897 | -17,058 | -54,929 |